Evaluation of the Migraceutics® Phase-Specific Dietary Supplement Regimen on Quality of Life, Work Productivity, and Biomarkers in Adult Migraineurs: The Migraceutics® START Study
Part of paid clinical trials in Lutherville-Timonium, Maryland.
- Sponsor
- Miracle Wellness LLC
- Study ID
- NCT07634146
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Menstrual Migraine
- Menstrual Migraine (MM) Headaches
- Migraine
- Migraine Disability
- Migraine Disease
- Migraine Disorder
- Migraine Headache
- Migraine in Adults
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- Foundational dietary supplement — DIETARY_SUPPLEMENTFoundational dietary supplement, self-administered daily.
- Luteal phase dietary supplement add-on — DIETARY_SUPPLEMENTAdd-on dietary supplement, self-administered to women with menstrual migraine during the luteal phase of their menstruation cycle.
- Migraine phase dietary supplement add-on — DIETARY_SUPPLEMENTAdd-on dietary supplement, self-administered during the symptomatic migraine phase.
- Reference dietary supplement — DIETARY_SUPPLEMENTReference comparator supplement, self-administered daily.
Study Details
The purpose of this study is to evaluate the impact of the Migraceutics® phase-specific dietary supplement regimen on quality of life, work productivity, and biomarkers in adult migraineurs.
Key Dates
- Start date
- Jul 8, 2026
- Status verified
- May 2026
- Primary completion
- Jun 30, 2028
- Completion
- Jun 30, 2028
Study Design
- Enrollment
- 920 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- No Intervention: Arm 1 - Care as usual (CAU)
- Sham Comparator: Arm 2 - Care as usual (CAU) + Reference dietary supplement
- Other: Arm 3 - Care as usual (CAU) + Foundational dietary supplement
- Other: Arm 4a - Care as usual (CAU) + Foundational dietary supplement + Migraine phase add-on supplement
- Other: Arm 4b - Care as usual (CAU) + Foundational dietary supplement + Luteal phase add-on supplement
Primary Outcome Measure
Changes from baseline in migraine-related quality of life [ Time Frame: Baseline, Month 1 through Month 6 ]
Central Contacts
- Principal Investigator443-220-3558
Locations (1)
| Facility | City | State | ZIP |
|---|---|---|---|
| Natural Migraceuticals | Lutherville-Timonium | Maryland | 21093 |
Find similar trials in Lutherville-Timonium, MD
By condition
By specialty
By research site
Related Studies
- Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)PHASE3 · Recruiting · AbbVie · Huntsville, Alabama
- Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17)PHASE3 · Enrolling By Invitation · AbbVie · Huntsville, Alabama
- A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic MigrainePHASE3 · Recruiting · H. Lundbeck A/S · New Haven, Connecticut
- NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar DisorderRecruiting · National Institute of Mental Health (NIMH) · Bethesda, Maryland